Welcome to the working week, everyone. We hope your weekend was invigorating. Now, of course, the time has come to resume the routine of meetings and deadlines. We relate. To cope, we are brewing our mandatory cup of stimulation and invite you to join us. After all, Monday is usually a busy day. So here are a few tidbits to help you along. Have a good one and stay in touch...
AstraZeneca Says Study Backs Brilinta Cost (Reuters)
Alkermes Pays $960M For Elan Drug Tech Unit (Bloomberg News)
Sanofi-Aventis Becomes Just Sanofi (Associated Press)
Chile Plans New Drug Regulation Agency (Pharma Times)
Crohn's Patients Respond To J&J's Stalera In Study (Reuters)
Dendreon, Provenge And Bulls And Bears (The Seattle Times)
Supplement Company Fined For Using Steroids In Diet Pills (Associated Press)
EDITOR'S NOTE: Please check this post for updates throughout the morning
2 Comments
It appears that healthcare really is a mainstream concern ...
http://dilbert.com/2011-05-09/
Fox News teaser. At the top of the hour (15 minutes) they are going to have something about why the government secretly pays parents for vaccine related autism.